Skip to main content
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Impact of systematic screening for AmpC-hyperproducing Enterobacterales intestinal carriage in intensive care unit patients

Fig. 2

Potential impact of rectal colonization surveillance on empirical antimicrobial therapy (EAT) and on use of carbapenems. a 3GCR-E: third-generation cephalosporins resistant Enterobacterales; ESBL-E: Extended-spectrum beta-lactamase producing Enterobacterales; HLAC-E: high-level expressed AmpC cephalosporinase-producing Enterobacterales. b EAT: empirical antimicrobial therapy. c CBP: carbapenem. d FEP: céfépime. e Potential carbapenem overuse and inappropriate EAT were determined by comparing EAT administered to EAT suggested by rectal carriage

Back to article page